Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity (NCT06978777) | Clinical Trial Compass
RecruitingNot Applicable
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
Switzerland12 participantsStarted 2026-01-21
Plain-language summary
The purpose of the study is to asses brown adipose tissue activity after a cold mild stimulus, preceded by 200mg caffeine or placebo administration.
Who can participate
Age range18 Years – 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* BMI 18.5 to 25 kg/m2
* Able to give informed consent as documented by signature
* Moderate caffeine consumption (1 to 3 cups of coffee per day)
* Increase of EE in response to mild cold of ≥ 5% of REE
Exclusion Criteria:
* Known hypersensitivity or allergy to caffeine
* Concomitant medication other than prescription free analgesics (paracetamol and NSAID) and oral contraceptives
* Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, cardiac arrhythmia, hypertension, diabetes mellitus, hyper- or hypothyroidism)
* History of depressive disorder or anxiety disorder
* Smoker / habitual tobacco use
* Habitual excessive alcohol use
* Regular consumption of caffeine containing energy drinks
* Weight change of \>5% within 3 months prior to inclusion
* Systolic blood pressure \>140 mmHg and/or diastolic blood pressure \> 95 mmHg.
* Resting heart rate \>90 bpm
* Hypersensitivity to cold (e.g. Raynaud syndrome)
* Known or suspected non-compliance, drug or alcohol abuse
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
* Enrolment of the investigator, his/her family members, employees, and other dependent persons
* Enrolment into another study using ionizing radiation within the previous 12 months.
* Pregnancy or lactation
What they're measuring
1
BAT SUVmean
Timeframe: 30 minutes after end of intervention in study visit A and B.